APA

Fournier A., Morinière P. H., Oprisiu R., Yverneau-Hardy P., Westeel P. F., Mazouz H., el Esper N., Ghazali A. & Boudailliez B. (19960305). 1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration. : Nephron.

Chicago

Fournier A, Morinière P H, Oprisiu R, Yverneau-Hardy P, Westeel P F, Mazouz H, el Esper N, Ghazali A and Boudailliez B. 19960305. 1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration. : Nephron.

Harvard

Fournier A., Morinière P. H., Oprisiu R., Yverneau-Hardy P., Westeel P. F., Mazouz H., el Esper N., Ghazali A. and Boudailliez B. (19960305). 1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration. : Nephron.

MLA

Fournier A, Morinière P H, Oprisiu R, Yverneau-Hardy P, Westeel P F, Mazouz H, el Esper N, Ghazali A and Boudailliez B. 1-alpha-Hydroxyvitamin D3 derivatives in the treatment of renal bone diseases: justification and optimal modalities of administration. : Nephron. 19960305.